Analytical Data
-
Gene name
SND1
- Application
-
Alternative Names
P100; TDRD11; P100 EBNA2 Co-Activator; 100 kDa coactivator; Tudor domain-containing protein 11
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7KZF4
-
Expression Region
Asp692~Arg910
-
Molecular Weight
29kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SND1 (Staphylococcal Nuclease and Tudor domain-containing protein 1) has garnered significant interest in recent years due to its multifaceted role in various cellular processes, including RNA metabolism, gene regulation, and signal transduction. This protein, characterized by its nuclease activity and Tudor domain, is implicated in diverse biological functions and has been associated with several pathological conditions, including cancer and neurodegenerative diseases. Understanding the structure and function of SND1 is critical not only for elucidating its biological roles but also for exploring its potential as a therapeutic target. The ability to express and purify recombinant SND1 protein facilitates in-depth biochemical and biophysical studies, which can clarify its interactions with RNA and other cellular molecules. Furthermore, the development of SND1 inhibitors could pave the way for novel treatment strategies. As such, research focusing on the recombinant expression of SND1 is essential for advancing our comprehension of its mechanisms in health and disease, highlighting the importance of this protein in molecular and cellular biology.
